[1]
A. H. Metzger, M. Anim, and C. Johnson, “Outcomes and Barriers to Use of Novel Sickle Cell Therapeutic Agents in a Community Health Center”, J. Hematol. Res., vol. 8, pp. 1–5, Jun. 2021.